Australia markets closed

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.92+0.10 (+0.42%)
At close: 04:00PM EDT
23.92 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
52,278
51,785
34,627
25,421
15,883
Selling general and administrative
17,708
17,076
16,569
11,412
4,800
Total operating expenses
69,986
68,861
51,196
36,833
20,683
Operating income or loss
-69,986
-68,861
-51,196
-36,833
-20,683
Total other income/expenses net
564
-803
12,810
6,196
-10,986
Income before tax
-63,933
-64,465
-37,685
-30,637
-31,669
Income from continuing operations
-63,933
-64,465
-37,685
-30,637
-31,669
Net income
-63,933
-64,465
-37,685
-30,637
-31,669
Net income available to common shareholders
-63,933
-64,465
-37,685
-30,637
-31,669
Basic EPS
-8.30
-61.80
-103.30
-26.90
-8.37
Diluted EPS
-8.30
-61.80
-103.30
-26.90
-8.37
Basic average shares
8,593
1,044
364.814
1,139
3,782
Diluted average shares
8,593
1,044
364.814
1,139
3,782